Last December, the Biden Administration declared war on corporate greed in healthcare. The announcement included a range of fronts in the war, from fighting bloated drug costs to attacking anticompetitive contracts that cause unnecessary waste for hospitals, payors, and the patients they serve. As reported by Healthcare Business News, the White House announcement led to

On May 10th, 2024, the U.S. Food and Drug Administration issued final guidance titled, “Remanufacturing of Medical Devices: Guidance for Industry, Entities That Perform Servicing or Remanufacturing, and Food and Drug Administration Staff.” AMDR wishes to highlight that the guidance “is not intended to address reprocessed single-use devices” and instead addresses the remanufacturing of reusable

Free CO2 Calculator to Help Hospital Sustainability Managers Track and Reduce Stubborn Supply Chain Emissions by Using Regulated, Reprocessed Single-Use Medical Devices from AMDR Members If the health sector worldwide were a country, they would be the fifth highest greenhouse gas emitting nation on the planet; use of reprocessed devices offers immediately available solution